CYTOFOTCPharmaceutical PreparationsFiscal year ends December 31
Altamira Therapeutics Ltd.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2025
$0.09+0.00 (0.00%)
Close on Oct 19, 2026
Share price
−$0.0089 (−9.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2024
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Diluted shares
- 0M
Valuation needs the share price. It fills in once daily prices are connected and converted from CHF.
Eleven years at a glance
Fiscal years 2014 to 2024, CHF
Revenue
–
Gross profit
–
Operating income
–
Net income
–
EPS, diluted
–
Free cash flow
–
Reported period